研究者業績

中島 昭

ナカシマ アキラ  (Nakashima Akira)

基本情報

所属
藤田医科大学 医学部 生理学1 客員教授
学位
博士(医学)(藤田保健衛生大学)

通称等の別名
ナカシマアキラ
J-GLOBAL ID
200901085737243854
researchmap会員ID
1000102599

研究キーワード

 3

論文

 56
  • Eita Uenishi, Yusuke Seino, Akira Nakashima, Katsuhiko Kato, Mitsuhiro Kato, Hiroshi Nagasaki, Kota Ishikawa, Takako Izumoto, Masaaki Yamamoto, Yutaka Takahashi, Yoshihisa Sugimura, Yutaka Oiso, Shin Tsunekawa
    Biochemical and Biophysical Research Communications 714 149940-149940 2024年6月  査読有り
  • Hisateru Yamaguchi, Satoshi Hara, Hiroshi Ichinose, Hiroshi Nagasaki, Akira Nakashima
    Biochemical and biophysical research communications 703 149698-149698 2024年4月9日  査読有り最終著者
    The gene encoding 5'-nucleotidase domain-containing protein 2 (NT5DC2) has been associated with neuropsychiatric disorders related to the abnormality of dopamine activity in the brain. However, its physiological functions remain unclear. In this study, we analyzed the features of NT5DC2 that influence its binding with tyrosine hydroxylase (TH) and its effects on dihydroxyphenylalanine (DOPA) synthesis, using NT5DC2 overexpressed in PC12D cells by the pCMV vector. Western blot analysis revealed that the purified NT5DC2-DYKDDDDK-tag (NT5DC2-tag) protein can bind with the phosphorylated form of recombinant human TH type 1 (rhTH1), apart from the endogenous TH in PC12D cells. Proteomic analysis by mass spectrometry revealed that the purified NT5DC2-tag protein has the potential to bind to 41 proteins with multiple phosphorylation sites in PC12D cells (NT5DC2 binding proteins: positive, 391 sites/41 proteins; and negative, 85 sites/27 proteins). Overexpression of NT5DC2 in PC12D cells decreased DOPA levels in the medium. When the lysate of PC12D cells overexpressing NT5DC2 was incubated at 37 °C, the phosphorylated form of endogenous TH in PC12D cells decreased. This decrease was also detected when phosphorylated rhTH1 was incubated with purified NT5DC2-tag. Overall, our results suggest that NT5DC2 regulates DOPA synthesis by promoting the dephosphorylation of TH, similar to a phosphatase. Therefore, our study provides useful information for understanding various disorders associated with abnormalities in dopamine levels in the brain.
  • Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, Shosuke Ito, Kazumasa Wakamatsu, Fabio A. Zucca, Luigi Zecca, Moussa Youdim, Maximilian Wulf, Peter Riederer, Johannes M. Dijkstra
    Journal of Neural Transmission 2023年3月20日  査読有り
    Abstract The dark pigment neuromelanin (NM) is abundant in cell bodies of dopamine (DA) neurons in the substantia nigra (SN) and norepinephrine (NE) neurons in the locus coeruleus (LC) in the human brain. During the progression of Parkinson’s disease (PD), together with the degeneration of the respective catecholamine (CA) neurons, the NM levels in the SN and LC markedly decrease. However, questions remain among others on how NM is associated with PD and how it is synthesized. The biosynthesis pathway of NM in the human brain has been controversial because the presence of tyrosinase in CA neurons in the SN and LC has been elusive. We propose the following NM synthesis pathway in these CA neurons: (1) Tyrosine is converted by tyrosine hydroxylase (TH) to L-3,4-dihydroxyphenylalanine (L-DOPA), which is converted by aromatic L-amino acid decarboxylase to DA, which in LC neurons is converted by dopamine β-hydroxylase to NE; (2) DA or NE is autoxidized to dopamine quinone (DAQ) or norepinephrine quinone (NEQ); and (3) DAQ or NEQ is converted to eumelanic NM (euNM) and pheomelanic NM (pheoNM) in the absence and presence of cysteine, respectively. This process involves proteins as cysteine source and iron. We also discuss whether the NM amounts per neuromelanin-positive (NM+) CA neuron are higher in PD brain, whether NM quantitatively correlates with neurodegeneration, and whether an active lifestyle may reduce NM formation.
  • Yu Kodani, Miho Kawata, Hidetaka Suga, Takatoshi Kasai, Chikafumi Ozone, Mayu Sakakibara, Atsushi Kuwahara, Shiori Taga, Hiroshi Arima, Toshiki Kameyama, Kanako Saito, Akira Nakashima, Hiroshi Nagasaki
    Frontiers in Endocrinology 13 941166-941166 2022年7月12日  査読有り
    Human stem cell-derived organoid culture enables the in vitro analysis of the cellular function in three-dimensional aggregates mimicking native organs, and also provides a valuable source of specific cell types in the human body. We previously established organoid models of the hypothalamic-pituitary (HP) complex using human pluripotent stem cells. Although the models are suitable for investigating developmental and functional HP interactions, we consider that isolated pituitary cells are also useful for basic and translational research on the pituitary gland, such as stem cell biology and regenerative medicine. To develop a method for the purification of pituitary cells in HP organoids, we performed surface marker profiling of organoid cells derived from human induced pluripotent stem cells (iPSCs). Screening of 332 human cell surface markers and a subsequent immunohistochemical analysis identified epithelial cell adhesion molecule (EpCAM) as a surface marker of anterior pituitary cells, as well as their ectodermal precursors. EpCAM was not expressed on hypothalamic lineages; thus, anterior pituitary cells were successfully enriched by magnetic separation of EpCAM+ cells from iPSC-derived HP organoids. The enriched pituitary population contained functional corticotrophs and their progenitors; the former responded normally to a corticotropin-releasing hormone stimulus. Our findings would extend the applicability of organoid culture as a novel source of human anterior pituitary cells, including stem/progenitor cells and their endocrine descendants.
  • Yu Kodani, Miho Kawata, Hidetaka Suga, Yoko S Kaneko, Akira Nakashima, Toshiki Kameyama, Kanako Saito, Hiroshi Nagasaki
    eNeuro 2022年4月18日  査読有り
    Hypothalamic melanin-concentrating hormone (MCH) neurons are important regulators of multiple physiological processes, such as sleep, feeding, and memory. Despite the increasing interest in their neuronal functions, the molecular mechanism underlying MCH neuron development remains poorly understood. We report that a three-dimensional culture of mouse embryonic stem cells (mESCs) can generate hypothalamic-like tissues containing MCH-positive neurons, which reproduce morphologic maturation, neuronal connectivity, and neuropeptide/neurotransmitter phenotype of native MCH neurons. Using this in vitro system, we demonstrate that Hedgehog (Hh) signaling serves to produce major neurochemical subtypes of MCH neurons characterized by the presence or absence of cocaine- and amphetamine-regulated transcript (CART). Without exogenous Hh signals, mESCs initially differentiated into dorsal hypothalamic/prethalamic progenitors and finally into MCH+CART+ neurons through a specific intermediate progenitor state. Conversely, activation of the Hh pathway specified ventral hypothalamic progenitors that generate both MCH+CART- and MCH+CART+ neurons. These results suggest that in vivo MCH neurons may originate from multiple cell lineages that arise through early dorsoventral patterning of the hypothalamus. Additionally, we found that Hh signaling supports the differentiation of mESCs into orexin/hypocretin neurons, a well-defined cell group intermingled with MCH neurons in the lateral hypothalamic area (LHA). The present study highlights and improves the utility of mESC culture in the analysis of the developmental programs of specific hypothalamic cell types.Significance StatementA growing body of literature has revealed the importance of hypothalamic melanin-concentrating hormone (MCH) neurons in energy homeostasis and the cognitive function, but their developmental biology remains relatively unknown. To establish a new approach for addressing this issue, we tested the ability of an in vitro differentiation system of mouse embryonic stem cells (mESCs) to recapitulate the development of MCH neurons. The mESC culture robustly generated MCH-positive neurons resembling native neurons in several aspects and provided evidence that Hedgehog (Hh) signaling is a key factor to produce neurochemical subtypes of MCH neurons. Our results demonstrate the suitability of mESC culture as a platform to study the molecular mechanisms underlying the development of MCH neurons and possibly of other hypothalamic cell types.
  • Toshiharu Nagatsu, Akira Nakashima, Hirohisa Watanabe, Shosuke Ito, Kazumasa Wakamatsu
    International Journal of Molecular Sciences 23(8) 4176-4176 2022年4月10日  
  • Miho Kawata, Yu Kodani, Mahito Ohkuma, Ei-Ichi Miyachi, Yoko S Kaneko, Akira Nakashima, Hidetaka Suga, Toshiki Kameyama, Kanako Saito, Hiroshi Nagasaki
    PloS one 17(11) e0276694 2022年  査読有り
    The hypothalamus is comprised of heterogenous cell populations and includes highly complex neural circuits that regulate the autonomic nerve system. Its dysfunction therefore results in severe endocrine disorders. Although recent experiments have been conducted for in vitro organogenesis of hypothalamic neurons from embryonic stem (ES) or induced pluripotent stem (iPS) cells, whether these stem cell-derived hypothalamic neurons can be useful for regenerative medicine remains unclear. We therefore performed orthotopic transplantation of mouse ES cell (mESC)-derived hypothalamic neurons into adult mouse brains. We generated electrophysiologically functional hypothalamic neurons from mESCs and transplanted them into the supraoptic nucleus of mice. Grafts extended their axons along hypothalamic nerve bundles in host brain, and some of them even projected into the posterior pituitary (PPit), which consists of distal axons of the magnocellular neurons located in hypothalamic supraoptic and paraventricular nuclei. The axonal projections to the PPit were not observed when the mESC-derived hypothalamic neurons were ectopically transplanted into the substantia nigra reticular part. These findings suggest that our stem cell-based orthotopic transplantation approach might contribute to the establishment of regenerative medicine for hypothalamic and pituitary disorders.
  • Akira Nakashima, Hisateru Yamaguchi, Mii Kondo, Takahiro Furumura, Yu Kodani, Yoko S Kaneko, Miho Kawata, Hiroshi Nagasaki, Toshiharu Nagatsu, Akira Ota
    Journal of neural transmission (Vienna, Austria : 1996) 2020年8月10日  査読有り
    5'-Nucleotidase domain-containing protein 2 (NT5DC2) has been revealed by genome-wide association studies (GWAS) as a gene implicated in neuropsychiatric disorders related to the abnormality of dopamine (DA) activity in the brain. Based on its amino acid sequence, NT5DC2 is assumed to be a member of the family of haloacid dehalogenase-type phosphatases; although there is no information about its function and structural conformation. We recently reported that NT5DC2 binds to tyrosine hydroxylase (TH) and that the down-regulation of NT5DC2 tended to increase DA synthesis. In this study, we investigated whether NT5DC2 could regulate the catalytic activity of TH, which converts tyrosine to DOPA, because the phosphorylation level of TH, controlled by protein kinases and phosphatases, is well known to regulate its catalytic activity. The down-regulation of NT5DC2 by siRNA increased mainly DOPA synthesis by TH in PC12D cells, although this down-regulation tended to increase the conversion of DOPA to DA by aromatic L-amino acid decarboxylase. The increased DOPA synthesis should be attributed to the catalytic activity of TH controlled by its phosphorylation, because Western blot analysis revealed that the down-regulation of NT5DC2 tended to increase the level of TH phosphorylated at its Ser residues, but not that of the TH protein. Moreover, the induction of kinase activity by forskolin markedly potentiated the phosphorylation of TH at its Ser40 in PC12D cells having down-regulated NT5DC2. Immunocytochemical analysis of PC12D cells demonstrated that NT5DC2, TH protein, and TH phosphorylated at its Ser40 were predominantly localized in the cytoplasm and that the localization of NT5DC2 and TH proteins partially overlapped. Collectively, our results indicate that NT5DC2 could work to inhibit the DOPA synthesis by decreasing the phosphorylation of TH at its Ser40. We propose that NT5DC2 might decrease this phosphorylation of TH by promoting dephosphorylation or by inhibiting kinase activity.
  • Nakashima A, Yamaguchi H, Kodani Y, Kaneko YS, Kawata M, Nagasaki H, Nagatsu T, Ota A
    Biochemical and biophysical research communications 516(4) 1060-1065 2019年9月  査読有り
  • Nagatsu T, Nakashima A, Ichinose H, Kobayashi K
    Journal of neural transmission (Vienna, Austria : 1996) 126(4) 397-409 2019年4月  査読有り
  • Akira Nakashima, Yu Kodani, Yoko S. Kaneko, Hiroshi Nagasaki, Akira Ota
    Journal of Neural Transmission 125(1) 9-15 2018年1月1日  査読有り
  • 中島 昭, 近藤 一直, 宮地 栄一, 飯塚 成志, 池本 和久, 石原 悟, 大熊 真人, 金子 葉子, 河合 房夫, 小谷 侑, 菅沼 由唯, 長崎 弘, 原田 信広, 吉田 友昭, 稲垣 秀人, 土田 邦博, 山口 央輝
    医学教育 48(5) 323-325 2017年10月  査読有り
  • Akira Nakashima, Syuhei Ohnuma, Yu Kodani, Yoko S. Kaneko, Hiroshi Nagasaki, Toshiharu Nagatsu, Akira Ota
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 472(4) 598-602 2016年4月  査読有り
  • Yoko S. Kaneko, Takeshi Takayanagi, Hiroshi Nagasaki, Yu Kodani, Akira Nakashima, Keiji Mori, Atsushi Suzuki, Mitsuyasu Itoh, Kazunao Kondo, Toshiharu Nagatsu, Miyuki Ota, Akira Ota
    JOURNAL OF NEURAL TRANSMISSION 122(6) 757-772 2015年6月  査読有り
  • Kaneko YS, Ota A, Nakashima A, Nagasaki H, Kodani Y, Mori K, Nagatsu T
    Journal of neural transmission (Vienna, Austria : 1996) 122(2) 187-199 2015年2月  査読有り
  • 長崎弘
    Fujita Medical Journal 1(1) 1-5 2015年  査読有り
    Objectives: According to our previous work, aripiprazole exerted a protective effect on hydrogen peroxide (H2O2)-treated PC12 cells; haloperidol did not. Because aripiprazole has distinct affinities to a set of neurotransmitter receptor subtypes, this study aimed to clarify which subtype is responsible for rescuing cells from 0.25 mM H2O2 exposure.Methods: A set of compounds, which are more specific to each subset of G-protein coupled receptors, wereexamined for their ability to mimic the pharmacological effects of aripiprazole or haloperidol, including their Ki values.The viability of PC12 cells cultured with test compounds with or without H2O2 was assessed using WST-8 reagent.Results: Results from in vitro studies using PC12 cells showed that agonism at serotonin 5-HT2C-receptors based on the antagonism against 5-HT2B-receptors played a significant role in resistingH2O2-induced cell death. However, the use of a specific 5-HT2B-receptor agonist instead of a 5-HT2B-receptor antagonist completely negated the effect of a specific 5-HT2C-receptor agonist. Furthermore, unlike the dopamine D1-receptor specific antagonist, none of the agonists of dopamine D2-, D3-, and D4-receptors ameliorated the cytopathic effects of H2O2.Conclusion: Antagonism at 5-HT2B-receptors is fundamental for the protection of PC12 cells against the cytopathiceffects caused by 0.25 mM H2O2. However, the role of negatively regulated cyclic adenosine monophosphate in this phenomenon requires further investigation.
  • 高柳 武志, 長崎 弘, 中島 昭, 金子 葉子, 小谷 侑, 近藤 一直, 永津 俊治, 濱田 洋司, 太田 深雪, 太田 明, 伊藤 光泰
    日本内分泌学会雑誌 90(1) 305-305 2014年4月  査読有り
  • Hiroshi Nagasaki, Akira Nakashima, Yoko S. Kaneko, Yu Kodani, Takeshi Takayanagi, Mitsuyasu Itoh, Kazunao Kondo, Toshiharu Nagatsu, Yoji Hamada, Miyuki Ota, Akira Ota
    JOURNAL OF NEURAL TRANSMISSION 121(1) 91-103 2014年1月  査読有り
  • 中島 昭, 鯉淵 典之, 石松 秀, 奥村 哲, 椎橋 実智男, 鈴木 敦子, 渡邉 マキノ
    医学教育 45 415-420 2014年  査読有り招待有り
  • 高柳 武志, 長崎 弘, 中島 昭, 金子 葉子, 森 啓至, 近藤 一直, 永津 俊治, 太田 深雪, 太田 明, 伊藤 光泰
    日本内分泌学会雑誌 89(1) 296-296 2013年4月  査読有り
  • Akira Nakashima, Akira Ota, Yoko S. Kaneko, Keiji Mori, Hiroshi Nagasaki, Toshiharu Nagatsu
    JOURNAL OF NEURAL TRANSMISSION 120(1) 49-54 2013年1月  査読有り
  • Akira Nakashima, Yoko S. Kaneko, Yu Kodani, Keiji Mori, Hiroshi Nagasaki, Toshiharu Nagatsu, Akira Ota
    Advances in Pharmacology 68 3-11 2013年  査読有り
  • Akira Ota, Akira Nakashima, Yoko S. Kaneko, Keiji Mori, Hiroshi Nagasaki, Takeshi Takayanagi, Mitsuyasu Itoh, Kazunao Kondo, Toshiharu Nagatsu, Miyuki Ota
    JOURNAL OF NEURAL TRANSMISSION 119(11) 1327-1342 2012年11月  査読有り
  • Keiji Mori, Yoko S. Kaneko, Akira Nakashima, Hiroshi Nagasaki, Toshiharu Nagatsu, Ikuko Nagatsu, Akira Ota
    CELLULAR AND MOLECULAR NEUROBIOLOGY 32(5) 777-785 2012年7月  査読有り
  • Yoko S. Kaneko, Akira Ota, Akira Nakashima, Keiji Mori, Ikuko Nagatsu, Toshiharu Nagatsu
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY 39(7) 599-607 2012年7月  査読有り
  • Akira Nakashima
    JOURNAL OF NEUROCHEMISTRY 120(2) 199-201 2012年1月  査読有り招待有り
  • 大槻眞嗣, 松井俊和, 松永佳世子, 森本紳一郎, 井野晶夫, 服部良信, 石原慎, 長田明子, 中島昭, 辻孝雄, 星長清隆
    医学教育 43(3) 211-214 2012年  査読有り
    1)新研修医が研修開始直後に必要となる手技を習得できることを目標としたスキルスラボを利用したトレーニングをオリエンテーション期間内に導入した.<br>2)新2年目研修医がトレーニングの内容を計画し,新研修医を指導し,3年目以上の上級医は,新2年目研修医の指導を支援する「屋根瓦方式」の指導体制の構築を目指した.<br>3)本トレーニングを開催したことにより研修医間の関係が良好なものとなり,新研修医に安心感を与えるといった波及効果がみられた.
  • Yoko S. Kaneko, Akira Nakashima, Keiji Mori, Toshiharu Nagatsu, Ikuko Nagatsu, Akira Ota
    NEURODEGENERATIVE DISEASES 10(1-4) 100-103 2012年  査読有り
  • Akira Nakashima, Keiji Mori, Yoko S. Kaneko, Nobuhiro Hayashi, Toshiharu Nagatsu, Akira Ota
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 407(2) 343-347 2011年4月  査読有り
  • 大槻眞嗣, 菊川薫, 江?誠治, 若月徹, 田中郁子, 外山宏, 長田明子, 石原慎, 中島昭, 小野雄一郎, 松井俊和
    医学教育 42(3) 135-140 2011年  査読有り
  • Goro Takami, Miyuki Ota, Akira Nakashima, Yoko S. Kaneko, Keiji Mori, Toshiharu Nagatsu, Akira Ota
    JOURNAL OF NEURAL TRANSMISSION 117(10) 1139-1153 2010年10月  査読有り
  • Keiji Mori, Yoko S. Kaneko, Akira Nakashima, Toshiharu Nagatsu, Ikuko Nagatsu, Akira Ota
    NEUROSCIENCE LETTERS 481(2) 126-130 2010年9月  査読有り
  • 中島昭, 長田明子, 石原慎, 大槻眞嗣, 橋本修二, 小野雄一郎, 松井俊和
    医学教育 41 429-434 2010年  査読有り
  • A. Nakashima, N. Hayashi, Y. S. Kaneko, K. Mori, E. L. Sabban, Toshiharu Nagatsu, A. Ota
    JOURNAL OF NEURAL TRANSMISSION 116(11) 1355-1362 2009年11月  査読有り
  • Yoko S. Kaneko, Akira Nakashima, Keiji Mori, Toshiharu Nagatsu, Ikuko Nagatsu, Akira Ota
    BRAIN RESEARCH 1279 9-20 2009年7月  査読有り
  • Akira Ota, Keiji Mori, Yoko S. Kaneko, Akira Nakashima, Ikuko Nagatsu, Toshiharu Nagatsu
    Stress, Neurotransmitters, and Hormones: Neuroendocrine and Genetic Mechanisms 1148 127-135 2008年  査読有り
  • 中島昭, 長田明子, 石原慎, 大槻眞嗣, 橋本修二, 小野雄一郎, 野村隆英, 松井俊和
    医学教育 39(6) 397-406 2008年  査読有り
    藤田保健衛生大学医学部入試では, 全入学者の約30%を推薦入試により選抜している.推薦入試入学者の入学後の成績が適正であるかどうかを検証するために, 入学直後に実施した基礎学力を測定するプレースメントテストの成績と, 入学後の1, 2年次の欠席状況と成績との関連性を比較検討した.<BR>1) 平成14年から17年までの入学生398名を, 推薦入試入学者 (126名), および, 一般入試の成績の上位1/2入学者 (137名) と下位1/2入学者 (135名) の3群に分類して解析した.<BR>2) 入学時のプレースメントテストの成績 (基礎学力) は, 一般上位>一般下位>推薦の順であったが, 入学後の成績は1, 2年次共に, 一般上位>推薦>一般下位となった.<BR>3) 推薦入試入学者の1, 2年次欠席コマ数は, 一般入試上位・下位入学者よりも少ない傾向にあった.<BR>4) 2年次の成績は1年次の成績とよく相関し, また, 2年次の欠席コマ数は1年次の欠席コマ数とも強く相関した.<BR>5) 入学時の基礎学力だけでなく, 1年次での勉強の取り組み方が, その後の成績に影響する重要な要因であることが示唆された.
  • Akira Nakashima, Nobuhiro Hayashi, Yoko S. Kaneko, Keiji Mori, Esther L. Sabban, Toshiharu Nagatsu, Akira Ota
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 363(3) 817-821 2007年11月  査読有り
  • Joseph R. Mazzulli, Amanda J. Mishizen, Benoit I. Giasson, David R. Lynch, Steven A. Thomas, Akira Nakashima, Toshiharu Nagatsu, Akira Ota, Harry Ischiropoulos
    JOURNAL OF NEUROSCIENCE 26(39) 10068-10078 2006年9月  査読有り
  • A Nakashima, N Hayashi, YS Kaneko, K Mori, H Egusa, T Nagatsu, A Ota
    JOURNAL OF NEUROSCIENCE RESEARCH 81(1) 110-120 2005年7月  査読有り
  • YS Kaneko, K Mori, A Nakashima, M Sawada, Nagatsu, I, A Ota
    JOURNAL OF NEUROCHEMISTRY 94(2) 393-404 2005年7月  査読有り
  • Ota M, Mori K, Nakashima A, Kaneko YS, Takahashi H, Ota A
    Clinical and experimental pharmacology & physiology 32(4) 279-287 2005年4月  査読有り
  • K Mori, YS Kaneko, A Nakashima, Nagatsu, I, H Takahashi, A Ota
    BRAIN RESEARCH 1039(1-2) 116-129 2005年3月  査読有り
  • Fujiwara K, Mori K, Kaneko YS, Nakashima A, Nagasaka A, Itoh M, Ota A
    Biochimica et biophysica acta 1670(3) 181-198 2004年2月  査読有り
  • Keiji Mori, Yoko S. Kaneko, Akira Nakashima, Kentaro Fujiwara, Ikuko Nagatsu, Akira Ota
    J. Neural Transm. 110 31-50 2003年  査読有り
  • Yoko S. Kaneko, Keiji Mori, Akira Nakashima, Ikuko Nagatsu, Akira Ota
    Neuroscience 116 7-12 2003年  査読有り
  • Ota M, Mori K, Nakashima A, Kaneko YS, Fujiwara K, Itoh M, Nagasaka A, Ota A
    Clinical and experimental pharmacology & physiology 29(11) 980-989 2002年11月  査読有り
  • A Nakashima, YS Kaneko, K Mori, K Fujiwara, T Tsugu, T Suzuki, T Nagatsu, A Ota
    JOURNAL OF NEUROCHEMISTRY 82(1) 202-206 2002年7月  査読有り
  • Akira Nakashima, Yoko S. Kaneko, Keiji Mori, Kentaro Fujiwara, Toshimitsu Tsugu, Takahiro Suzuki, Toshiharu Nagatsu, Akira Ota
    J. Neurochem. 82 202-206 2002年  査読有り
  • Miyuki Ota, Keiji Mori, Akira. Nakashima, Yoko S. Kaneko, Kentaro Fujiwara, Keiko Ikemoto, Hiroshi Koga, Toshiharu Nagatsu, Akira Ota
    Molecular Psychiatry 6 315-319 2001年  査読有り

MISC

 40

書籍等出版物

 9

講演・口頭発表等

 28

担当経験のある科目(授業)

 8

共同研究・競争的資金等の研究課題

 7

教育内容・方法の工夫(授業評価等を含む)

 1
  • 件名
    生理学授業へのe-learningによる自己学習システムの導入
    開始年月日
    2011/01
    終了年月日
    2011/03
    概要
    e-learning教材「一歩一歩学ぶ生命科学」をmoodleシステムに組み込み、生理学講義受講前の学生に自己学習をさせることにより生理学講義の理解を助けるシステムを構築した。

作成した教科書、教材、参考書

 1
  • 件名
    新訂・生理学実習書、日本生理学会教育委員会編/ 編集委員/ 南江堂
    終了年月日
    2013/10
    概要
    生理学実習を行うための教員・学生のための実習書を作成した(分担編集)

教育方法・教育実践に関する発表、講演等

 2
  • 件名
    生理学授業へのe-learningによる自己学習システムの導入事例の報告
    終了年月日
    2011/10
    概要
    第43回藤田医学会で報告した。
  • 件名
    学生指導で注意していること(藤田保健衛生大学・医学部・指導教員懇談会・講演)
    終了年月日
    2012/07
    概要
    指導教員に対する学生の指導方法について

その他教育活動上特記すべき事項

 2
  • 件名
    学内医学教育ワークショップの開催(第27回〜57回、計30回)
    開始年月日
    2008/04
    終了年月日
    2015/09
    概要
    医学教育企画室による学内教員向けワークショップの開催と運営(試験問題の作り方、ポートフォリオ導入、PBLテュータトレーニングなど)
  • 件名
    基礎統合実習の開催(2005年・第1回〜2015年・第11回、学外活動)
    開始年月日
    2005/08
    終了年月日
    2015/08
    概要
    生理学・病理学・生化学など基礎医学系全ての知識を基にして、学生が自ら考えた仮設を実験で検証する「真実を探求」することを目的とした実習を全国の医学生を集めて開催